UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Kelsey Natsuhara, MD

Title(s)resident physician, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard College, Cambridge, MABA05/2013Human Developmental and Regenerative Biology
    Harvard Medical School, Boston, MAMD05/2018

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA. Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3502-3509. PMID: 31228134.
      View in: PubMed
    2. Natsuhara KH, Losk K, King TA, Lin NU, Camuso K, Golshan M, Pochebit S, Brock JE, Bunnell CA, Freedman RA. Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria. Oncologist. 2019 05; 24(5):595-602. PMID: 30076279.
      View in: PubMed
    3. Pinder LF, Natsuhara KH, Burke TF, Lozo S, Oguttu M, Miller L, Nelson BD, Eckardt MJ. Nurse-midwives' ability to diagnose acute third- and fourth-degree obstetric lacerations in western Kenya. BMC Pregnancy Childbirth. 2017 Sep 18; 17(1):308. PMID: 28923011.
      View in: PubMed
    4. Losk K, Freedman RA, Lin NU, Golshan M, Pochebit SM, Lester SC, Natsuhara K, Camuso K, King TA, Bunnell CA. Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation. J Oncol Pract. 2017 09; 13(9):e815-e820. PMID: 28858535.
      View in: PubMed
    5. Theodore LN, Hagedorn EJ, Cortes M, Natsuhara K, Liu SY, Perlin JR, Yang S, Daily ML, Zon LI, North TE. Distinct Roles for Matrix Metalloproteinases 2 and 9 in Embryonic Hematopoietic Stem Cell Emergence, Migration, and Niche Colonization. Stem Cell Reports. 2017 05 09; 8(5):1226-1241. PMID: 28416284.
      View in: PubMed
    6. Katya Losk, Rachel A. Freedman, Nancy U. Lin, Mehra Golshan, Susan Lester, Stephen Pochebit, Kelsey Natsuhara, Kristen Camuso, Tari A. King, Craig A. Bunnell. Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times. Journal of Clinical Oncology. 2017 Mar 10; 35(8_suppl):166-166.
      View in: Publisher Site
    7. Lindsay Theodore, Mauricio Cortes, Kelsey Natsuhara, Sarah Liu, Virginie Esain, Trista E. North. Distinct roles for matrix metalloproteinases 2 and 9 in embryonic hematopoietic stem cell production. Experimental Hematology. 2016 Sep 1; 44(9):s103.
      View in: Publisher Site